Chuangzhong X. Deng
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Soft Tissue Sarcoma Following TKI Treatment Failure: A Retrospective Study.
Journal: Drug design, development and therapy
Published: December 09, 2025
Analysis of peripheral blood monocyte subsets in chronic myelomonocytic leukemia: a single-center study
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 03, 2025
Erratum to "Economic burden attributable to hospital-acquired infections among tumor patients from a large regional cancer center in Southern China" [Am J Infect Control. 2024;52(8):934-940].
Journal: American journal of infection control
Published: October 06, 2025
Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 26, 2025
Spatial Transcriptional Dynamics of CD74⁺ B Cells in Tertiary Lymphoid Structures Drive Immune Evolution in Penile Squamous Cell Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 28, 2025
Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma.
Journal: Molecular cancer
Published: April 25, 2025
Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Osteosarcoma: A Real-World Study.
Journal: Drug design, development and therapy
Published: November 08, 2024
Development and validation of a novel immune-related prognostic model and the potential metastatic mechanism in synovial sarcoma.
Journal: Frontiers in immunology
Published: June 13, 2024
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single-arm, exploratory phase II trial.
Journal: Cancer medicine
Published: April 29, 2024
Economic burden attributable to hospital-acquired infections among tumor patients from a large regional cancer center in Southern China.
Journal: American journal of infection control
Published: January 19, 2024
MOF@COF Nanocapsules Enhance Soft Tissue Sarcoma Treatment: Synergistic Effects of Photodynamic Therapy and PARP Inhibition on Tumor Growth Suppression and Immune Response Activation.
Journal: Advanced healthcare materials
Published: November 08, 2023
Last Updated: 09/26/2026